Certain proteases are involved in Alzheimer’s disease (AD) and their erroneous control may contribute to the pathology onset and progression. In this study we evaluated the cerebral expression of eight proteases, involved in both AβPP processing and extracellular matrix remodeling. Among these proteases, ADAM10, ADAMTS1, Cathepsin D, and Meprin β show a significantly higher mRNAs expression in sporadic AD subjects versus controls, while ADAMTS1, Cathepsin D, and Meprin β show an increment also at the protein level. These data indicate that transcriptional events affecting brain proteases are activated in AD patients, suggesting a link between proteolysis and AD.
PotterH, GranicA, CaneusJ (2016) Role of trisomy 21 mosaicism in sporadic and familial Alzheimer’s disease. Curr Alzheimer Res13, 7–17.
4.
NizzariM, ThellungS, CorsaroA, VillaV, PaganoA, PorcileC, RussoC, FlorioT (2012) Neurodegeneration in Alzheimer disease: Role of amyloid precursor protein and presenilin 1 intracellular signaling. J Toxicol2012, 187297.
5.
RussoC, DolciniV, SalisS, VeneziaV, ViolaniE, CarloP, ZambranoN, RussoT, SchettiniG (2002) Signal transduction through tyrosine-phosphorylated carboxy-terminal fragments of APP via an enhanced interaction with Shc/Grb2 adaptor proteins in reactive astrocytes of Alzheimer’s disease brain. Ann N Y Acad Sci973, 323–333.
6.
AndrewRJ, KellettKAB, ThinakaranG, HooperNM (2016) A Greek tragedy: The growing complexity of Alzheimer amyloid precursor protein proteolysis. J Biol Chem291, 19235–19244.
7.
van GoorH, MelenhorstWBWH, TurnerAJ, HolgateST (2009) Adamalysins in biology and disease. J Pathol219, 277–286.
DeussM, ReissK, HartmannD (2008) Part-time alpha-secretases: The functional biology of ADAM 9, 10 and 17. Curr Alzheimer Res5, 187–201.
10.
BenesP, VetvickaV, FusekM (2008) Cathepsin D–many functions of one aspartic protease. Crit Rev Oncol Hematol68, 12–28.
11.
Becker-PaulyC, PietrzikCU (2016) The metalloprotease Meprin β is an alternative β-secretase of APP. Front Mol Neurosci9, 159.
12.
MorawskiM, FilippovM, TziniaA, TsilibaryE, VargovaL (2014) ECM in brain aging and dementia. Prog Brain Res214, 207–227.
13.
BrkicM, BalusuS, LibertC, VandenbrouckeRE (2015) Friends or foes: Matrix metalloproteinases and their multifaceted roles in neurodegenerative diseases. Mediators Inflamm2015, 620581.
14.
HaapasaloA, KovacsDM (2011) The many substrates of presenilin/γ-secretase. J Alzheimers Dis25, 3–28.
15.
MedoroA, BartollinoS, MignognaD, PassarellaD, PorcileC, PaganoA, FlorioT, NizzariM, GuerraG, Di MarcoR, IntrieriM, RaimoG, RussoC (2018) Complexity and selectivity of γ-secretase cleavage on multiple substrates: Consequences in Alzheimer’s disease and cancer. J Alzheimers Dis61, 1–15.
16.
MiguelRF, PollakA, LubecG (2005) Metalloproteinase ADAMTS-1 but not ADAMTS-5 is manifold overexpressed in neurodegenerative disorders as Down syndrome, Alzheimer’s and Pick’s disease. Mol Brain Res133, 1–5.
17.
CastelnuovoM, MassoneS, TassoR, FiorinoG, GattiM, RobelloM, GattaE, BergerA, StrubK, FlorioT, DieciG, CanceddaR, PaganoA (2010) An Alu-like RNA promotes cell differentiation and reduces malignancy of human neuroblastoma cells. FASEB J24, 4033–4046.
18.
GavazzoP, VellaS, MarchettiC, NizzariM, CanceddaR, PaganoA (2011) Acquisition of neuron-like electrophysiological properties in neuroblastoma cells by controlled expression of NDM29 ncRNA. J Neurochem119, 989–1001.
19.
AlloisioS, GarbatiP, VitiF, DanteS, BarbieriR, ArnaldiG, PetrelliA, GigoniA, GiannoniP, QuartoR, NobileM, VassalliM, PaganoA (2017) Generation of a functional human neural network by NDM29 overexpression in neuroblastoma cancer cells. Mol Neurobiol54, 6097–6106.
20.
MassoneS, CiarloE, VellaS, NizzariM, FlorioT, RussoC, CanceddaR, PaganoA (2012) NDM29, a RNA polymerase III-dependent non coding RNA, promotes amyloidogenic processing of APP and amyloid β secretion. Biochim Biophys Acta1823, 1170–1177.
21.
BackstromJR, LimGP, CullenMJ, TökésZA (1996) Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40). J Neurosci16, 7910–7919.
BroderC, Becker-PaulyC (2013) The metalloproteases meprin α and meprin β: Unique enzymes in inflammation, neurodegeneration, cancer and fibrosis. Biochem J450, 253–264.
24.
BreigO, YatesM, NeaudV, CouchyG, GrigolettoA, LucchesiC, ProxJ, Zucman-RossiJ, Becker-PaulyC, RosenbaumJ (2017) Metalloproteinase meprin α regulates migration and invasion of human hepatocarcinoma cells and is a mediator of the oncoprotein Reptin. Oncotarget8, 7839–7851.
LottazD, MaurerCA, NoëlA, BlacherS, HugueninM, NievergeltA, NiggliV, KernA, MüllerS, SeiboldF, FriessH, Becker-PaulyC, StöckerW, SterchiEE (2011) Enhanced activity of meprin-α, a pro-migratory and pro-angiogenic protease, in colorectal cancer. PLoS One6, e26450.
27.
SchönherrC, BienJ, IsbertS, WichertR, ProxJ, AltmeppenH, KumarS, WalterJ, LichtenthalerSF, WeggenS, GlatzelM, Becker-PaulyC, PietrzikCU (2016) Generation of aggregation prone N-terminally truncated amyloid β peptides by meprin β depends on the sequence specificity at the cleavage site. Mol Neurodegener11, 19.
28.
JeffersonT, ČauševićM, Auf dem KellerU, SchillingO, IsbertS, GeyerR, MaierW, TschickardtS, JumpertzT, WeggenS, BondJS, OverallCM, PietrzikCU, Becker-PaulyC (2011) Metalloprotease meprin beta generates nontoxic N-terminal amyloid precursor protein fragments in vivo. J Biol Chem286, 27741–27750.
29.
JeffersonT, Auf dem KellerU, BellacC, MetzVV, BroderC, HedrichJ, OhlerA, MaierW, MagdolenV, SterchiE, BondJS, JayakumarA, TraupeH, ChalarisA, Rose-JohnS, PietrzikCU, PostinaR, OverallCM, Becker-PaulyC (2013) The substrate degradome of meprin metalloproteases reveals an unexpected proteolytic link between meprin β and ADAM10. Cell Mol Life Sci70, 309–333.
30.
WeberS, NiessenMT, ProxJ, Lullmann-RauchR, SchmitzA, SchwanbeckR, BlobelCP, JorissenE, de StrooperB, NiessenCM, SaftigP (2011) The disintegrin/metalloproteinase Adam10 is essential for epidermal integrity and Notch-mediated signaling. Development138, 495–505.
31.
PranjolM, GutowskiN, HannemannM, WhatmoreJ (2015) The potential role of the proteases cathepsin D and cathepsin L in the progression and metastasis of epithelial ovarian cancer. Biomolecules5, 3260–3279.
32.
Liaudet-CoopmanE, BeaujouinM, DerocqD, GarciaM, Glondu-LassisM, Laurent-MathaV, PréboisC, RochefortH, VignonF (2006) Cathepsin D: Newly discovered functions of a long-standing aspartic protease in cancer and apoptosis. Cancer Lett237, 167–179.
33.
NomuraT, KatunumaN (2005) Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells. J Med Invest52, 1–9.
34.
AustenBM, StephensDJ (1995) Cleavage of a beta-amyloid precursor sequence by cathepsin D. Biomed Pept Proteins Nucleic Acids1, 243–246.
35.
HaasU, SparksDL (1996) Cortical cathepsin D activity and immunolocalization in Alzheimer disease, critical coronary artery disease, and aging. Mol Chem Neuropathol29, 1–14.
36.
TekirianTL (2001) Commentary: Abeta N-terminal isoforms: Critical contributors in the course of AD pathophysiology. J Alzheimers Dis3, 241–248.
37.
WangH, SangN, ZhangC, RaghupathiR, TanziRE, SaundersA (2015) Cathepsin L mediates the degradation of novel APP C-terminal fragments. Biochemistry54, 2806–2816.
38.
MainBF, JonesPJ, MacGillivrayRT, BanfieldDK (1991) Apolipoprotein E genotyping using the polymerase chain reaction and allele-specific oligonucleotide primers. J Lipid Res32, 183–187.
39.
PennaI, VellaS, GigoniA, RussoC, CanceddaR, PaganoA (2011) Selection of candidate housekeeping genes for normalization in human postmortem brain samples. Int J Mol Sci12, 5461–5470.
40.
IntrieriM, RinaldiA, ScudieroO, AutieroG, CastaldoG, NardoneG (2010) Low expression of human β-defensin 1 in duodenum of celiac patients is partially restored by a gluten-free diet. Clin Chem Lab Med48, 489–492.
RussoC, AngeliniG, DapinoD, PicciniA, PiomboG, SchettiniG, ChenS, TellerJK, ZaccheoD, GambettiP, TabatonM (1998) Opposite roles of apolipoprotein E in normal brains and in Alzheimer’s disease. Proc Natl Acad Sci U S A95, 15598–15602.
43.
KobayashiT, HonkeK, GasaS, FujiiT, MaguchiS, MiyazakiT, MakitaA (1992) Proteolytic processing sites producing the mature form of human cathepsin D. Int J Biochem24, 1487–1491.
GattaLB, AlbertiniA, RavidR, FinazziD (2002) Levels of beta-secretase BACE and alpha-secretase ADAM10 mRNAs in Alzheimer hippocampus. Neuroreport13, 2031–2033.
46.
RussoC, SaidoTC, DeBuskLM, TabatonM, GambettiP, TellerJK (1997) Heterogeneity of water-soluble amyloid beta-peptide in Alzheimer’s disease and Down’s syndrome brains. FEBS Lett409, 411–416.
47.
FusekM, VetvickaV (1994) Mitogenic function of human procathepsin D: The role of the propeptide. Biochem J303(Pt 3), 775–780.
48.
VetvickaV, VetvickovaJ, FusekM (1999) Anti-human procathepsin D activation peptide antibodies inhibit breast cancer development. Breast Cancer Res Treat57, 261–269.
